Scientists are racing to create a vaccine for COVID-19 in less than one year. Cambridge, Massachusetts based biotechnology company, Moderna, Inc. and the National Institute of Allergy and Infectious Diseases have co-developed the vaccine known as mRNA-1273, which is now in Phase 3 clinical trials with 30,000 adult volunteers. For an update on the phase 3 trials, Newt is joined by Dr. Tal Zaks, Chief Medical Officer at Moderna.

 Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

<p>Scientists are racing to create a vaccine for COVID-19 in less than one year. Cambridge, Massachusetts based biotechnology company, Moderna, Inc. and the National Institute of Allergy and Infectious Diseases have co-developed the vaccine known as mRNA-1273, which is now in Phase 3 clinical trials with 30,000 adult volunteers. For an update on the phase 3 trials, Newt is joined by Dr. Tal Zaks, Chief Medical Officer at Moderna.</p><p> </p> Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>

Join former House Speaker, professor, historian, and futurist Newt Gingrich as he shares his lifetime of knowledge and access to the world’s most interesting minds in a new series that covers all aspects of our society. From history to health, national security to science, Newt offers stories, conversations, and context to uncover new perspectives, knowledge and insight. This podcast isn’t about politics; it’s about exploring the past, present, and future to understand where we’ve been and where we’re going. Welcome to Newt’s World, a podcast for independent thinkers.

Newt's World

Episode 120: COVID-19 Vaccine

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b01f80d3-b7f8-402f-a054-ae2800126fd5/transcript

Advertisement